Update note from QuotedData

Summary by AI BETAClose X

Oakley Capital Investments Limited's portfolio is well-positioned to benefit from AI advancements, with companies like vLex, IU Group, and TechInsights expected to see AI as an accelerant rather than a disruptor due to their proprietary data and expertise. The company is also gaining direct AI exposure through its partnership with Touring Capital. In the first half of 2026, Oakley Capital Investments achieved a NAV total return of 6.0%, largely driven by earnings growth, and despite challenging market conditions, the report suggests that resilient earnings, continued capital deployment, AI-driven value creation, and share buybacks provide a strong case for a narrowing of its current 33.2% discount to NAV.

Disclaimer*

Oakley Capital Investments Limited
27 August 2026
 

 A picture containing text, sign, clipart Description automatically generated

Oakley Capital Investments - Update note from QuotedData

27 August 2026

On the right side of AI

The rapid progress of AI (especially agentic AI) has raised legitimate concerns over the business models of some companies within the software sector, affecting several private equity trusts exposed to these sorts of businesses. We believe these concerns are overstated for the companies in Oakley Capital Investments' (OCI) portfolio. These appear well positioned to benefit from the next phase of AI adoption.

OCI's portfolio is focused on businesses that benefit from having proprietary data (that the business owns or controls access to), specialist information, and deep sector expertise. For portfolio companies such as vLex, IU Group, and TechInsights, OCI's manager believes AI is more likely to be an accelerant than a disruptor, increasing the value of the underlying business. OCI is also building direct exposure to AI businesses through its partnership with Touring Capital.

Portfolio performance remains strong, with NAV total return of 6.0% in the first half of 2026 (80% of the underlying portfolio performance was driven by earnings growth), despite challenging economic and geopolitical conditions. We believe resilient earnings growth, continued capital deployment, AI-related value creation, and ongoing share buybacks provide a compelling basis for a narrowing of OCI's share price discount to NAV, which has widened to 33.2%.

Full Research:

https://quoteddata.com/research/oakley-capital-investments-on-the-right-side-of-ai-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Oakley Capital Investments Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA
50 Gresham Street | London EC2V 7AY
Tel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings